Page last updated: 2024-09-04
canertinib and spc-839
canertinib has been researched along with spc-839 in 2 studies
Compound Research Comparison
Studies (canertinib) | Trials (canertinib) | Recent Studies (post-2010) (canertinib) | Studies (spc-839) | Trials (spc-839) | Recent Studies (post-2010) (spc-839) |
---|---|---|---|---|---|
124 | 9 | 65 | 37 | 0 | 18 |
Protein Interaction Comparison
Protein | Taxonomy | canertinib (IC50) | spc-839 (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.0538 | |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 1.3 | |
Transcription factor AP-1 | Homo sapiens (human) | 0.008 | |
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.008 | |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.344 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2527 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.618 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.008 | |
Transcription factor p65 | Homo sapiens (human) | 0.008 | |
Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.344 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Das, D; Hong, J | 1 |
Reviews
1 review(s) available for canertinib and spc-839
Article | Year |
---|---|
Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2019 |
Other Studies
1 other study(ies) available for canertinib and spc-839
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |